Skip to main content
Top
Published in: Virology Journal 1/2011

Open Access 01-12-2011 | Short report

Detection of HIV-1 dual infections in highly exposed treated patients

Authors: Guadalupe Andreani, Constanza Espada, Ana Ceballos, Juan Ambrosioni, Alejandro Petroni, Dora Pugliese, María Belén Bouzas, Silvia Fernandez Giuliano, Mercedes C Weissenbacher, Marcelo Losso, Jorge Benetucci, Jean K Carr, Liliana Martínez Peralta

Published in: Virology Journal | Issue 1/2011

Login to get access

Abstract

Background

Genetic characterization of HIV-1 in Argentina has shown that BF recombinants predominate among heterosexuals and injecting drug users, while in men who have sex with men the most prevalent form is subtype B.

Objectives

The aim of this work was to investigate the presence of HIV dual infections in HIV-infected individuals with high probability of reinfection

Study design

Blood samples were collected from 23 HIV positive patients with the risk of reinfection from Buenos Aires. A fragment of the HIV gene pol was amplified and phylogenetic analyses were performed. Antiretroviral drug resistance patterns of all the sequences were analyzed.

Results

Five dual infections were detected with four patients coinfected with subtype B and BF recombinants and one patient was coinfected with two BF recombinants presenting different recombination patterns. Prolonged infection with a stable clinical condition was observed in the five individuals. Resistance mutation patterns were different between the predominant and the minority strains.

Conclusions

Our results show that HIV dual infection can occur with closely related subtypes, and even with different variants of the same recombinant form in certain populations. Clinical observations showed neither aggressive disease progression nor impact on the resistance patterns in the dually-infected patients.
Appendix
Available only for authorised users
Literature
2.
go back to reference Blick G, Kagan RM, Coakley E, Petropoulos C, Maroldo L, Greiger-Zanlungo P, Gretz S, Garton T: The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient. J Infect Dis 2007, 195: 1250-1259. 10.1086/512240CrossRefPubMed Blick G, Kagan RM, Coakley E, Petropoulos C, Maroldo L, Greiger-Zanlungo P, Gretz S, Garton T: The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient. J Infect Dis 2007, 195: 1250-1259. 10.1086/512240CrossRefPubMed
3.
go back to reference Pernas M, Casado C, Fuentes R, Perez-Elias MJ, Lopez-Galindez C: A dual superinfection and recombination within HIV-1 subtype B 12 years after primoinfection. J Acquir Immune Defic Syndr 2006, 42: 12-18. 10.1097/01.qai.0000214810.65292.73CrossRefPubMed Pernas M, Casado C, Fuentes R, Perez-Elias MJ, Lopez-Galindez C: A dual superinfection and recombination within HIV-1 subtype B 12 years after primoinfection. J Acquir Immune Defic Syndr 2006, 42: 12-18. 10.1097/01.qai.0000214810.65292.73CrossRefPubMed
4.
go back to reference Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Petropoulos CJ, Richman DD, Little SJ: HIV drug resistance acquired through superinfection. Aids 2005, 19: 1251-1256. 10.1097/01.aids.0000180095.12276.acCrossRefPubMed Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Petropoulos CJ, Richman DD, Little SJ: HIV drug resistance acquired through superinfection. Aids 2005, 19: 1251-1256. 10.1097/01.aids.0000180095.12276.acCrossRefPubMed
5.
go back to reference Leontiev VV, Maury WJ, Hadany L: Drug induced superinfection in HIV and the evolution of drug resistance. Infect Genet Evol 2008, 8: 40-50. 10.1016/j.meegid.2007.09.008CrossRefPubMed Leontiev VV, Maury WJ, Hadany L: Drug induced superinfection in HIV and the evolution of drug resistance. Infect Genet Evol 2008, 8: 40-50. 10.1016/j.meegid.2007.09.008CrossRefPubMed
6.
go back to reference Avila MM, Pando MA, Carrion G, Peralta LM, Salomon H, Carrillo MG, Sanchez J, Maulen S, Hierholzer J, Marinello M, et al.: Two HIV-1 epidemics in Argentina: different genetic subtypes associated with different risk groups. J Acquir Immune Defic Syndr 2002, 29: 422-426.CrossRefPubMed Avila MM, Pando MA, Carrion G, Peralta LM, Salomon H, Carrillo MG, Sanchez J, Maulen S, Hierholzer J, Marinello M, et al.: Two HIV-1 epidemics in Argentina: different genetic subtypes associated with different risk groups. J Acquir Immune Defic Syndr 2002, 29: 422-426.CrossRefPubMed
7.
go back to reference Espinosa A, Vignoles M, Carrillo MG, Sheppard H, Donovan R, Peralta LM, Rossi D, Radulich G, Salomon H, Weissenbacher M: Intersubtype BF recombinants of HIV-1 in a population of injecting drug users in Argentina. J Acquir Immune Defic Syndr 2004, 36: 630-636. 10.1097/00126334-200405010-00012CrossRefPubMed Espinosa A, Vignoles M, Carrillo MG, Sheppard H, Donovan R, Peralta LM, Rossi D, Radulich G, Salomon H, Weissenbacher M: Intersubtype BF recombinants of HIV-1 in a population of injecting drug users in Argentina. J Acquir Immune Defic Syndr 2004, 36: 630-636. 10.1097/00126334-200405010-00012CrossRefPubMed
8.
go back to reference Segura M, Sosa Estani S, Marone R, Bautista CT, Pando MA, Eyzaguirre L, Sanchez JL, Carr JK, Montano SM, Weissenbacher M, Avila MM: Buenos Aires cohort of men who have sex with men: prevalence, incidence, risk factors, and molecular genotyping of HIV type 1. AIDS Res Hum Retroviruses 2007, 23: 1322-1329. 10.1089/aid.2007.0063CrossRefPubMed Segura M, Sosa Estani S, Marone R, Bautista CT, Pando MA, Eyzaguirre L, Sanchez JL, Carr JK, Montano SM, Weissenbacher M, Avila MM: Buenos Aires cohort of men who have sex with men: prevalence, incidence, risk factors, and molecular genotyping of HIV type 1. AIDS Res Hum Retroviruses 2007, 23: 1322-1329. 10.1089/aid.2007.0063CrossRefPubMed
9.
go back to reference Carr JK, Nadai Y, Eyzaguirre L, Saad MD, Khakimov MM, Yakubov SK, Birx DL, Graham RR, Wolfe ND, Earhart KC, Sanchez JL: Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan. J Acquir Immune Defic Syndr 2005, 39: 570-575.PubMed Carr JK, Nadai Y, Eyzaguirre L, Saad MD, Khakimov MM, Yakubov SK, Birx DL, Graham RR, Wolfe ND, Earhart KC, Sanchez JL: Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan. J Acquir Immune Defic Syndr 2005, 39: 570-575.PubMed
10.
go back to reference Petroni AD, Gabriel , Pryluka D, Rotryng F, Bortolozzi R, Lopardo G, Bouzas MB, Zapiola I, Garone D, Rodríguez C, Chiocconi E, Lázaro ME, Murano F, Maranzana A, Oliva SM, Aparicio M, Beltrán M, Benetucci J: Update on Primary HIV-1 Resistance in Argentina: Emergence of Mutations Conferring High-Level Resistance to Nonnucleoside Reverse Transcriptase Inhibitors in Drug-Naive Patients. JAIDS 2006, 42: 506-510. 10.1097/01.qai.0000222285.44460.e2PubMed Petroni AD, Gabriel , Pryluka D, Rotryng F, Bortolozzi R, Lopardo G, Bouzas MB, Zapiola I, Garone D, Rodríguez C, Chiocconi E, Lázaro ME, Murano F, Maranzana A, Oliva SM, Aparicio M, Beltrán M, Benetucci J: Update on Primary HIV-1 Resistance in Argentina: Emergence of Mutations Conferring High-Level Resistance to Nonnucleoside Reverse Transcriptase Inhibitors in Drug-Naive Patients. JAIDS 2006, 42: 506-510. 10.1097/01.qai.0000222285.44460.e2PubMed
11.
go back to reference Carobene MG, Rubio AE, Carrillo MG, Maligne GE, Kijak GH, Quarleri JF, Salomon H: Differences in frequencies of drug resistance-associated mutations in the HIV-1 pol gene of B subtype and BF intersubtype recombinant samples. J Acquir Immune Defic Syndr 2004, 35: 207-209. 10.1097/00126334-200402010-00018CrossRefPubMed Carobene MG, Rubio AE, Carrillo MG, Maligne GE, Kijak GH, Quarleri JF, Salomon H: Differences in frequencies of drug resistance-associated mutations in the HIV-1 pol gene of B subtype and BF intersubtype recombinant samples. J Acquir Immune Defic Syndr 2004, 35: 207-209. 10.1097/00126334-200402010-00018CrossRefPubMed
12.
go back to reference Prado JG, Parkin NT, Clotet B, Ruiz L, Martinez-Picado J: HIV type 1 fitness evolution in antiretroviral-experienced patients with sustained CD4+ T cell counts but persistent virologic failure. Clin Infect Dis 2005, 41: 729-737. 10.1086/432619CrossRefPubMed Prado JG, Parkin NT, Clotet B, Ruiz L, Martinez-Picado J: HIV type 1 fitness evolution in antiretroviral-experienced patients with sustained CD4+ T cell counts but persistent virologic failure. Clin Infect Dis 2005, 41: 729-737. 10.1086/432619CrossRefPubMed
13.
go back to reference Gallant JE: The M184V mutation: what it does, how to prevent it, and what to do with it when it's there. AIDS Read 2006, 16: 556-559.PubMed Gallant JE: The M184V mutation: what it does, how to prevent it, and what to do with it when it's there. AIDS Read 2006, 16: 556-559.PubMed
14.
go back to reference Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD: Update of the drug resistance mutations in HIV-1: December 2009. Top HIV Med 2009, 17: 138-145.PubMed Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD: Update of the drug resistance mutations in HIV-1: December 2009. Top HIV Med 2009, 17: 138-145.PubMed
15.
go back to reference Paredes R, Sagar M, Marconi VC, Hoh R, Martin JN, Parkin NT, Petropoulos CJ, Deeks SG, Kuritzkes DR: In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine. J Virol 2009, 83: 2038-2043. 10.1128/JVI.02154-08PubMedCentralCrossRefPubMed Paredes R, Sagar M, Marconi VC, Hoh R, Martin JN, Parkin NT, Petropoulos CJ, Deeks SG, Kuritzkes DR: In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine. J Virol 2009, 83: 2038-2043. 10.1128/JVI.02154-08PubMedCentralCrossRefPubMed
16.
go back to reference Casado C, Garcia S, Rodriguez C, del Romero J, Bello G, Lopez-Galindez C: Different evolutionary patterns are found within human immunodeficiency virus type 1-infected patients. J Gen Virol 2001, 82: 2495-2508.CrossRefPubMed Casado C, Garcia S, Rodriguez C, del Romero J, Bello G, Lopez-Galindez C: Different evolutionary patterns are found within human immunodeficiency virus type 1-infected patients. J Gen Virol 2001, 82: 2495-2508.CrossRefPubMed
17.
go back to reference Ramos A, Hu DJ, Nguyen L, Phan KO, Vanichseni S, Promadej N, Choopanya K, Callahan M, Young NL, McNicholl J, et al.: Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol 2002, 76: 7444-7452. 10.1128/JVI.76.15.7444-7452.2002PubMedCentralCrossRefPubMed Ramos A, Hu DJ, Nguyen L, Phan KO, Vanichseni S, Promadej N, Choopanya K, Callahan M, Young NL, McNicholl J, et al.: Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol 2002, 76: 7444-7452. 10.1128/JVI.76.15.7444-7452.2002PubMedCentralCrossRefPubMed
18.
go back to reference Piantadosi A, Chohan B, Chohan V, McClelland RS, Overbaugh J: Chronic HIV-1 infection frequently fails to protect against superinfection. PLoS Pathog 2007, 3: e177. 10.1371/journal.ppat.0030177PubMedCentralCrossRefPubMed Piantadosi A, Chohan B, Chohan V, McClelland RS, Overbaugh J: Chronic HIV-1 infection frequently fails to protect against superinfection. PLoS Pathog 2007, 3: e177. 10.1371/journal.ppat.0030177PubMedCentralCrossRefPubMed
19.
go back to reference Fang G, Weiser B, Kuiken C, Philpott SM, Rowland-Jones S, Plummer F, Kimani J, Shi B, Kaul R, Bwayo J, et al.: Recombination following superinfection by HIV-1. Aids 2004, 18: 153-159. 10.1097/00002030-200401230-00003CrossRefPubMed Fang G, Weiser B, Kuiken C, Philpott SM, Rowland-Jones S, Plummer F, Kimani J, Shi B, Kaul R, Bwayo J, et al.: Recombination following superinfection by HIV-1. Aids 2004, 18: 153-159. 10.1097/00002030-200401230-00003CrossRefPubMed
20.
go back to reference Jurriaans S, Kozaczynska K, Zorgdrager F, Steingrover R, Prins JM, van der Kuyl AC, Cornelissen M: A sudden rise in viral load is infrequently associated with HIV-1 superinfection. J Acquir Immune Defic Syndr 2008, 47: 69-73. 10.1097/QAI.0b013e3181582d6fCrossRefPubMed Jurriaans S, Kozaczynska K, Zorgdrager F, Steingrover R, Prins JM, van der Kuyl AC, Cornelissen M: A sudden rise in viral load is infrequently associated with HIV-1 superinfection. J Acquir Immune Defic Syndr 2008, 47: 69-73. 10.1097/QAI.0b013e3181582d6fCrossRefPubMed
21.
go back to reference Blackard JT, Mayer KH: HIV superinfection in the era of increased sexual risk-taking. Sex Transm Dis 2004, 31: 201-204. 10.1097/01.OLQ.0000118082.45312.1FCrossRefPubMed Blackard JT, Mayer KH: HIV superinfection in the era of increased sexual risk-taking. Sex Transm Dis 2004, 31: 201-204. 10.1097/01.OLQ.0000118082.45312.1FCrossRefPubMed
22.
go back to reference Kijak GH, McCutchan FE: HIV diversity, molecular epidemiology, and the role of recombination. Curr Infect Dis Rep 2005, 7: 480-488. 10.1007/s11908-005-0051-8CrossRefPubMed Kijak GH, McCutchan FE: HIV diversity, molecular epidemiology, and the role of recombination. Curr Infect Dis Rep 2005, 7: 480-488. 10.1007/s11908-005-0051-8CrossRefPubMed
Metadata
Title
Detection of HIV-1 dual infections in highly exposed treated patients
Authors
Guadalupe Andreani
Constanza Espada
Ana Ceballos
Juan Ambrosioni
Alejandro Petroni
Dora Pugliese
María Belén Bouzas
Silvia Fernandez Giuliano
Mercedes C Weissenbacher
Marcelo Losso
Jorge Benetucci
Jean K Carr
Liliana Martínez Peralta
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2011
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-8-392

Other articles of this Issue 1/2011

Virology Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine